fluoxetine has been researched along with Paralysis in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
Excerpt | Relevance | Reference |
---|---|---|
" We evaluated the following 3 widely used empirical therapies for the ability to reduce the severity of paralysis in a mouse model of EV-D68 infection: (1) human intravenous immunoglobulin (hIVIG), (2) fluoxetine, and (3) dexamethasone." | 3.85 | Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis. ( Clarke, P; Hixon, AM; Tyler, KL, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hixon, AM | 1 |
Clarke, P | 1 |
Tyler, KL | 1 |
Bermingham, DP | 1 |
Hardaway, JA | 1 |
Snarrenberg, CL | 1 |
Robinson, SB | 1 |
Folkes, OM | 1 |
Salimando, GJ | 1 |
Jinnah, H | 1 |
Blakely, RD | 1 |
Seliger, GM | 1 |
Hornstein, A | 1 |
3 other studies available for fluoxetine and Paralysis
Article | Year |
---|---|
Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis.
Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Dexamethasone; Disease Models, Animal; Enterov | 2017 |
Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo.
Topics: Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Dopamine; Dopamine Plasma Membrane | 2016 |
Serotonin, fluoxetine, and pseudobulbar affect.
Topics: Aged; Behavior; Fluoxetine; Humans; Male; Paralysis; Serotonin Antagonists | 1989 |